Hyundai Bioscience's Prostate Cancer Drug Candidate 'Penetrium' Approved for Treatment Use
AI 요약 정보
- Hyundai Bioscience gets Penetrium use approval for trial patient
- Prostate cancer patient approved for 6 more months of dosing
- Company plans free 1,080-tablet, 180-day supply